Related Experiment Video
Updated: May 27, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma
Taslima Bhuiyan1, Mathew S Maurer
1Division of Cardiology, Columbia University Medical Center, New York, NY, USA.
Current Cardiovascular Risk Reports
|November 15, 2011
Summary
Heart failure with preserved ejection fraction (HFPEF) is a growing concern in aging populations. Research is exploring its complex causes and potential new treatment strategies to improve patient outcomes.
Area of Science:
- Cardiology
- Geriatrics
- Internal Medicine
Background:
- Heart failure with preserved ejection fraction (HFPEF) prevalence is rising due to population aging.
- HFPEF carries morbidity and mortality rates comparable to heart failure with reduced ejection fraction (HFREF).
- Diagnosis of HFPEF is challenging, particularly in older adults with multiple comorbidities.
Purpose of the Study:
- To review the diagnostic challenges and underlying pathophysiology of HFPEF.
- To highlight the lack of effective treatments and propose a novel therapeutic approach.
Main Methods:
- Review of recent literature on HFPEF pathophysiology and diagnosis.
- Analysis of current diagnostic guidelines and therapeutic strategies.
Main Results:
- HFPEF involves multiple pathophysiological mechanisms including abnormal relaxation, ventricular-vascular coupling, chronotropic incompetence, volume overload, and endothelial dysfunction.
- Current treatments do not demonstrably decrease morbidity and mortality in HFPEF patients.
Conclusions:
- A novel, multidisciplinary, and multistage treatment strategy incorporating pharmacologic and non-pharmacologic therapeutics is proposed for HFPEF.
- Further research is needed to validate this comprehensive approach for managing HFPEF.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...